These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 18625665)

  • 1. Neurobehavioral profile and brain imaging study of the 22q13.3 deletion syndrome in childhood.
    Philippe A; Boddaert N; Vaivre-Douret L; Robel L; Danon-Boileau L; Malan V; de Blois MC; Heron D; Colleaux L; Golse B; Zilbovicius M; Munnich A
    Pediatrics; 2008 Aug; 122(2):e376-82. PubMed ID: 18625665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 22q13.3 deletion syndrome: a recognizable malformation syndrome associated with marked speech and language delay.
    Cusmano-Ozog K; Manning MA; Hoyme HE
    Am J Med Genet C Semin Med Genet; 2007 Nov; 145C(4):393-8. PubMed ID: 17926345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global brain dysmyelination with above-average verbal skills in 18q- syndrome with a 17 Mb terminal deletion.
    Netzer C; Helmstaedter C; Ehrbrecht A; Engels H; Schwanitz G; Urbach H; Schröder R; Weber RG; Kornblum C
    Acta Neurol Scand; 2006 Aug; 114(2):133-8. PubMed ID: 16867037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterisation of patients with subtelomeric 22q abnormalities using chromosome specific array-based comparative genomic hybridisation.
    Koolen DA; Reardon W; Rosser EM; Lacombe D; Hurst JA; Law CJ; Bongers EM; van Ravenswaaij-Arts CM; Leisink MA; van Kessel AG; Veltman JA; de Vries BB
    Eur J Hum Genet; 2005 Sep; 13(9):1019-24. PubMed ID: 15986041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between deletion size and important phenotypes expands the genomic region of interest in Phelan-McDermid syndrome (22q13 deletion syndrome).
    Sarasua SM; Dwivedi A; Boccuto L; Rollins JD; Chen CF; Rogers RC; Phelan K; DuPont BR; Collins JS
    J Med Genet; 2011 Nov; 48(11):761-6. PubMed ID: 21984749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal insulin to improve developmental delay in children with 22q13 deletion syndrome: an exploratory clinical trial.
    Schmidt H; Kern W; Giese R; Hallschmid M; Enders A
    J Med Genet; 2009 Apr; 46(4):217-22. PubMed ID: 18948358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further delineation of deletion 1p36 syndrome in 60 patients: a recognizable phenotype and common cause of developmental delay and mental retardation.
    Battaglia A; Hoyme HE; Dallapiccola B; Zackai E; Hudgins L; McDonald-McGinn D; Bahi-Buisson N; Romano C; Williams CA; Brailey LL; Zuberi SM; Carey JC
    Pediatrics; 2008 Feb; 121(2):404-10. PubMed ID: 18245432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome 22q13.3 deletion syndrome with a de novo interstitial 22q13.3 cryptic deletion disrupting SHANK3.
    Delahaye A; Toutain A; Aboura A; Dupont C; Tabet AC; Benzacken B; Elion J; Verloes A; Pipiras E; Drunat S
    Eur J Med Genet; 2009; 52(5):328-32. PubMed ID: 19454329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a test battery (NPM-X) for neuropsychological and neuromotor examination of children with developmental disabilities or mental retardation. A theoretical and clinical study.
    Gjaerum B
    Acta Psychiatr Scand Suppl; 1997; 390():1-55. PubMed ID: 9212855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive and behavior profile of preschool children with chromosome 22q11.2 deletion.
    Gerdes M; Solot C; Wang PP; Moss E; LaRossa D; Randall P; Goldmuntz E; Clark BJ; Driscoll DA; Jawad A; Emanuel BS; McDonald-McGinn DM; Batshaw ML; Zackai EH
    Am J Med Genet; 1999 Jul; 85(2):127-33. PubMed ID: 10406665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A de novo 7.9 Mb deletion in 22q13.2→qter in a boy with autistic features, epilepsy, developmental delay, atopic dermatitis and abnormal immunological findings.
    Chen CP; Lin SP; Chern SR; Tsai FJ; Wu PC; Lee CC; Chen YT; Chen WL; Wang W
    Eur J Med Genet; 2010; 53(5):329-32. PubMed ID: 20541044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion 22q13.3 syndrome.
    Phelan MC
    Orphanet J Rare Dis; 2008 May; 3():14. PubMed ID: 18505557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interstitial 22q13 deletions: genes other than SHANK3 have major effects on cognitive and language development.
    Wilson HL; Crolla JA; Walker D; Artifoni L; Dallapiccola B; Takano T; Vasudevan P; Huang S; Maloney V; Yobb T; Quarrell O; McDermid HE
    Eur J Hum Genet; 2008 Nov; 16(11):1301-10. PubMed ID: 18523453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amygdalar volume and behavioral development in autism.
    Munson J; Dawson G; Abbott R; Faja S; Webb SJ; Friedman SD; Shaw D; Artru A; Dager SR
    Arch Gen Psychiatry; 2006 Jun; 63(6):686-93. PubMed ID: 16754842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neuropsychology of 22q11 deletion syndrome. A neuropsychiatric study of 100 individuals.
    Niklasson L; Gillberg C
    Res Dev Disabil; 2010; 31(1):185-94. PubMed ID: 19815377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Communication and speech disorders and their relationship with psychic development and mental disorders in 8 year old children from the Lódź area].
    Kolasińska M; Rabe-Jabłońska J
    Psychiatr Pol; 2005; 39(2):357-70. PubMed ID: 15881630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital hypotonia in a child with a de novo 22q13 monosomy and 2pter duplication: a clinical and molecular genetic study.
    Trabacca A; Losito L; De Rinaldis M; Gennaro L
    J Child Neurol; 2011 Feb; 26(2):235-8. PubMed ID: 20921566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case report of monozygotic twins with Smith-Magenis syndrome.
    Hicks M; Ferguson S; Bernier F; Lemay JF
    J Dev Behav Pediatr; 2008 Feb; 29(1):42-6. PubMed ID: 18301319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Worster-Drought syndrome: poorly recognized despite severe and persistent difficulties with feeding and speech.
    Clark M; Harris R; Jolleff N; Price K; Neville BG
    Dev Med Child Neurol; 2010 Jan; 52(1):27-32. PubMed ID: 19824895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No evidence for submicroscopic 22qter deletions in patients with features suggestive for Angelman syndrome.
    de Vries BB; Tyson J; Winter RM; Malcolm S
    Am J Med Genet; 2002 Apr; 109(2):117-20. PubMed ID: 11977159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.